(Q39029761)

8 September 2017

title

Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway (English)

1 reference

8 September 2017

2 references

ChEBI release 2020-05-28

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

Frederic Carsten Schmeel

1

1 reference

8 September 2017

Leonard Christopher Schmeel

2

1 reference

8 September 2017

Young Kim

3

1 reference

8 September 2017

Ingo G H Schmidt-Wolf

4

1 reference

8 September 2017

publication date

27 January 2014

1 reference

8 September 2017

published in

Hematological Oncology

1 reference

8 September 2017

volume

32

1 reference

8 September 2017

issue

4

1 reference

8 September 2017

page(s)

197-204

1 reference

Multiple myeloma: evolving genetic events and host interactions

8 September 2017

cites work

1 reference

Autologous hematopoietic stem-cell transplantation for multiple myeloma

21 January 2018

1 reference

Investigational treatments for multiple myeloma

21 January 2018

1 reference

Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets

21 January 2018

1 reference

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

Wnt signaling in disease and in development

21 January 2018

1 reference

Wnt signaling: is the party in the nucleus?

21 January 2018

1 reference

beta-catenin is a target for the ubiquitin-proteasome pathway

21 January 2018

1 reference

Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression

21 January 2018

1 reference

Wnt signaling in B-cell neoplasia

21 January 2018

1 reference

Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma.

21 January 2018

1 reference

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

21 January 2018

1 reference

Initial genome sequencing and analysis of multiple myeloma

21 January 2018

1 reference

beta-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model

21 January 2018

1 reference

In vivo efficacy of the diuretic agent ethacrynic acid against multiple myeloma

21 January 2018

1 reference

Postharvest UV-C-irradiated grapes as a potential source for producing stilbene-enriched red wines

21 January 2018

1 reference

Resveratrol, pterostilbene, and piceatannol in vaccinium berries

21 January 2018

1 reference

Production of stilbenoids from the callus of Arachis hypogaea: a novel source of the anticancer compound piceatannol

21 January 2018

1 reference

Antiproliferative and anti-invasive effect of piceatannol, a polyphenol present in grapes and wine, against hepatoma AH109A cells

21 January 2018

1 reference

The grape component piceatannol induces apoptosis in DU145 human prostate cancer cells via the activation of extrinsic and intrinsic pathways

21 January 2018

1 reference

TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis

21 January 2018

1 reference

AKT/mTOR as Novel Targets of Polyphenol Piceatannol Possibly Contributing to Inhibition of Proliferation of Cultured Prostate Cancer Cells

21 January 2018

1 reference

Piceatannol suppresses breast cancer cell invasion through the inhibition of MMP-9: involvement of PI3K/AKT and NF-κB pathways

21 January 2018

1 reference

The AKT kinase is activated in multiple myeloma tumor cells

21 January 2018

1 reference

Downstream effectors of oncogenic ras in multiple myeloma cells

21 January 2018

1 reference

In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model

21 January 2018

1 reference

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

21 January 2018

1 reference

Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling

21 January 2018

1 reference

Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.

21 January 2018

1 reference

Transcriptional silencing of the Wnt-antagonist DKK1 by promoter methylation is associated with enhanced Wnt signaling in advanced multiple myeloma

21 January 2018

1 reference

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

21 January 2018

1 reference

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

21 January 2018

1 reference

Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

21 January 2018

1 reference

Tandem autologous stem cell transplantation in high-risk de novo multiple myeloma: final results of the prospective and randomized IFM 99-04 protocol

21 January 2018

1 reference

7 January 2021

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

1 reference

7 January 2021

Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines.

1 reference

7 January 2021

Use of potato disc and brine shrimp bioassays to detect activity and isolate piceatannol as the antileukemic principle from the seeds of Euphorbia lagascae

1 reference

7 January 2021

Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts

1 reference

7 January 2021

Piceatannol inhibits MMP-9-dependent invasion of tumor necrosis factor-α-stimulated DU145 cells by suppressing the Akt-mediated nuclear factor-κB pathway

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.2122

1 reference

8 September 2017

1 reference